SU11248 (sunitinib malate) therapy in patients with refractory metastatic breast cancer: preliminary safety and efficacy results from a phase II study
2006 ◽
Vol 4
(2)
◽
pp. 172
◽
Keyword(s):
Phase Ii
◽
2015 ◽
Vol 51
◽
pp. S291-S292
◽